Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen, +10

The Lancet Oncology

UrologyMedicineVaccine TargetImmunologyTherapeutic Vaccine +7

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A. Madan, +14

Clinical Cancer Research

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer

Christopher R. Heery, Nuhad K. Ibrahim, Philip M. Arlen, +14

JAMA Oncology

Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin

Varun Jain, Mahsa Mohebtash, M.E. Rodrigo, +3

Journal of Immunotherapy

Antithymocyte GlobulinImmunologyPathologyImmune SystemImmunotherapy +17

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho, +377

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Efficacy +4

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

Ravi A. Madan, Mahsa Mohebtash, Jeffrey Schlom, +1

Expert Opinion on Biological Therapy

Prostate Cancer VaccinesImmunologyImmunotherapyTumor ImmunologyOncology +16

Video intervention increases participation of black breast cancer patients in therapeutic trials

Brandi N. Robinson, Antoinette F. Newman, Eshetu Tefera, +15

npj Breast Cancer

A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver

James L. Gulley, Ravi A. Madan, Kwong-Yok Tsang, +6

Expert Opinion on Biological Therapy

Overall survival (OS) analysis of a phase l trial of a vector-based vaccine (PSA-TRICOM) and ipilimumab (Ipi) in the treatment of metastatic castration-resistant prostate cancer (mCRPC).

Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen, +6

Journal of Clinical Oncology

ImmunologyCd4 T Cell ResponsesImmune Cell TherapyImmunotherapyOverall Survival +18

Phase I trial of targeted therapy with PSA-TRICOM vaccine (V) and ipilimumab (ipi) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Mahsa Mohebtash, Ravi A. Madan, Philip M. Arlen, +8

Journal of Clinical Oncology

↓ PsaImmunologyImmune RegulationImmunotherapeuticsCd4 T Cell Responses +18